This site uses cookies to improve your browsing experience. By using this site, you agree to their use. Cookie Information

WCLC, Barcelona, Spain 7-10 September 2019

Targeting NRG1-fusions in lung adenocarcinoma: afatinib as a novel potential treatment strategy

Michaël Duruisseaux, Janessa J. Laskin, Khaled Tolba, Eva Branden, Yasushi Goto, Robert C. Doebele, Parneet Kaur Cheema, Jacques Cadranel, Martin R. Jones, Alexander E. Drilon, Domenico Trombetta, Lucia A. Muscarella, Agnieszka Cseh, Flavio Solca, Stephen V. Liu 

wclc_2019_duruisseaux_nrg1_lung.jpg

Related Materials

Learn more about the science behind this poster in the videos, papers and other materials below.

Targeting NRG1-fusions in lung adenocarcinoma: afatinib as a novel potential treatment strategy

Weinberg et al. ESMO-WCGC 2019 P-291

FOR HEALTHCARE PROFESSIONALS ONLY.

image